Silver Spike Investment Corp. (SSIC)
USD 10.74
(1.27%)
USD 10.74
(1.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.1 Million USD | 100.22% |
| 2022 | 4.04 Million USD | 5637.73% |
| 2021 | -73.07 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 654.19 Million USD | 30421.73% |
| 2023 Q1 | 2.45 Billion USD | 119988.84% |
| 2023 Q4 | 2.14 Million USD | -99.93% |
| 2023 Q3 | 2.91 Billion USD | 0.8% |
| 2023 Q2 | 2.89 Billion USD | 17.73% |
| 2023 FY | 8.1 Million USD | 100.22% |
| 2022 Q2 | 745.04 Thousand USD | -99.99% |
| 2022 FY | 4.04 Million USD | 5637.73% |
| 2022 Q4 | 2.04 Million USD | 89.58% |
| 2022 Q3 | 1.07 Million USD | 44.9% |
| 2022 Q1 | 10.07 Billion USD | 0.0% |
| 2021 FY | -73.07 Thousand USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 97.346% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 72.766% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 97.516% |
| Cosmos Health Inc. | 4.34 Million USD | -86.285% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 436.183% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 88.911% |
| Cronos Group Inc. | 6.99 Million USD | -15.902% |
| Incannex Healthcare Limited | 12 Thousand USD | -67421.658% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 2774.125% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 80.639% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 1186.739% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 2.837% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 2.837% |
| SCYNEXIS, Inc. | 124.51 Million USD | 93.493% |
| Safety Shot Inc | -74.45 Thousand USD | 10982.253% |
| Theratechnologies Inc. | 62.12 Million USD | 86.958% |
| Alpha Teknova, Inc. | 10.29 Million USD | 21.303% |
| Universe Pharmaceuticals INC | 10.07 Million USD | 19.6% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 98.347% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -70.761% |
| Dynavax Technologies Corporation | 182.11 Million USD | 95.551% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 98.163% |
| Radius Health, Inc. | 307.71 Million USD | 97.367% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -1362.64% |
| Alvotech | -69.42 Million USD | 111.672% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 98.118% |
| SIGA Technologies, Inc. | 122.09 Million USD | 93.364% |
| Shineco, Inc. | 882.16 Thousand USD | -818.487% |
| Journey Medical Corporation | 52.52 Million USD | 84.573% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -93.326% |
| Embecta Corp. | 749.9 Million USD | 98.92% |
| Harrow Health, Inc. | 90.55 Million USD | 91.052% |
| Procaps Group, S.A. | 239.56 Million USD | 96.618% |
| Biofrontera Inc. | 16.62 Million USD | 51.268% |
| DURECT Corporation | 6.83 Million USD | -18.615% |
| PainReform Ltd. | -15 Thousand USD | 54117.327% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 98.453% |
| OptiNose, Inc. | 62.35 Million USD | 87.005% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -165.296% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 97.384% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 75.803% |
| ProPhase Labs, Inc. | 16.23 Million USD | 50.104% |
| Phibro Animal Health Corporation | 312.48 Million USD | 97.407% |
| Procaps Group S.A. | 239.56 Million USD | 96.618% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -522.319% |
| Viatris Inc. | 6.43 Billion USD | 99.874% |
| Rockwell Medical, Inc. | 8.7 Million USD | 6.909% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 85.156% |
| Tilray Brands, Inc. | 223.35 Million USD | 96.372% |
| PetIQ, Inc. | 252.74 Million USD | 96.794% |
| Talphera, Inc. | -4.89 Million USD | 265.528% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 99.561% |
| Alimera Sciences, Inc. | 61.17 Million USD | 86.754% |
| Assertio Holdings, Inc. | 125.04 Million USD | 93.52% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 119063.427% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 70.12% |
| Hempacco Co., Inc. | -1.21 Million USD | 766.424% |
| Alvotech | -69.42 Million USD | 111.672% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 98.858% |
| Kamada Ltd. | 52.59 Million USD | 84.594% |
| Currenc Group, Inc. | 17.35 Million USD | 53.316% |
| Indivior PLC | 907 Million USD | 99.107% |
| Evoke Pharma, Inc. | 4.97 Million USD | -62.744% |
| Flora Growth Corp. | 17.73 Million USD | 54.321% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 436.183% |
| Evolus, Inc. | 140.52 Million USD | 94.234% |
| HUTCHMED (China) Limited | 453.55 Million USD | 98.214% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 97.644% |
| Akanda Corp. | 111.44 Thousand USD | -7170.23% |